Cargando…
Humoral response to the BBIBP-CorV vaccine over time in healthcare workers with or without exposure to SARS-CoV-2
SARS-CoV-2-specific humoral response was analyzed over time in a group of healthcare workers with or without exposure to SARS-CoV-2, who underwent vaccination with BBIBP-CorV (Sinopharm) vaccine in Argentina. Seroconversion rates in unexposed subjects after the first and second doses were 40 % and 1...
Autores principales: | Badano, María Noel, Sabbione, Florencia, Keitelman, Irene, Pereson, Matias, Aloisi, Natalia, Colado, Ana, Ramos, María Victoria, Ortiz Wilczyñski, Juan Manuel, Pozner, Roberto Gabriel, Castillo, Luis, Wigdorovitz, Georgina, E.de Bracco, María Marta, Fink, Susana, Chuit, Roberto, Baré, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761547/ https://www.ncbi.nlm.nih.gov/pubmed/35091231 http://dx.doi.org/10.1016/j.molimm.2022.01.009 |
Ejemplares similares
-
SARS-CoV-2 Breakthrough Infections after Third Doses Boost IgG Specific Salivary and Blood Antibodies
por: Badano, María Noel, et al.
Publicado: (2023) -
BBIBP-CorV: Hepatitis: case report
Publicado: (2022) -
TNF-α Levels in Respiratory Samples Are Associated with SARS-CoV-2 Infection
por: Pereson, Matias J., et al.
Publicado: (2022) -
BBIBP-CorV: Anterior uveitis: case report
Publicado: (2022) -
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
por: Jeewandara, Chandima, et al.
Publicado: (2022)